TWI732158B - 使用食慾喪失控制化合物之組合物及方法 - Google Patents

使用食慾喪失控制化合物之組合物及方法 Download PDF

Info

Publication number
TWI732158B
TWI732158B TW107142255A TW107142255A TWI732158B TW I732158 B TWI732158 B TW I732158B TW 107142255 A TW107142255 A TW 107142255A TW 107142255 A TW107142255 A TW 107142255A TW I732158 B TWI732158 B TW I732158B
Authority
TW
Taiwan
Prior art keywords
caprelin
day
composition
serum
animals
Prior art date
Application number
TW107142255A
Other languages
English (en)
Chinese (zh)
Other versions
TW201924680A (zh
Inventor
鄒勒斯比爾
羅迪斯琳達
海寧恩斯特
狄凡瑞傑高皮那西
Original Assignee
美商雅瑞塔那醫療公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商雅瑞塔那醫療公司 filed Critical 美商雅瑞塔那醫療公司
Publication of TW201924680A publication Critical patent/TW201924680A/zh
Application granted granted Critical
Publication of TWI732158B publication Critical patent/TWI732158B/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Dermatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW107142255A 2012-09-27 2013-09-27 使用食慾喪失控制化合物之組合物及方法 TWI732158B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261706164P 2012-09-27 2012-09-27
US61/706,164 2012-09-27

Publications (2)

Publication Number Publication Date
TW201924680A TW201924680A (zh) 2019-07-01
TWI732158B true TWI732158B (zh) 2021-07-01

Family

ID=50339468

Family Applications (3)

Application Number Title Priority Date Filing Date
TW109121986A TW202106298A (zh) 2012-09-27 2013-09-27 使用食慾喪失控制化合物之組合物及方法
TW102135177A TWI667024B (zh) 2012-09-27 2013-09-27 使用食慾喪失控制化合物之組合物及方法
TW107142255A TWI732158B (zh) 2012-09-27 2013-09-27 使用食慾喪失控制化合物之組合物及方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
TW109121986A TW202106298A (zh) 2012-09-27 2013-09-27 使用食慾喪失控制化合物之組合物及方法
TW102135177A TWI667024B (zh) 2012-09-27 2013-09-27 使用食慾喪失控制化合物之組合物及方法

Country Status (18)

Country Link
US (1) US11090292B2 (enExample)
EP (3) EP3524260B1 (enExample)
JP (2) JP6779618B2 (enExample)
KR (6) KR20230097201A (enExample)
CN (2) CN105072909A (enExample)
AR (2) AR092713A1 (enExample)
AU (2) AU2013323349B2 (enExample)
BR (1) BR112015006282B1 (enExample)
CA (1) CA2886091C (enExample)
DK (1) DK3524260T3 (enExample)
ES (1) ES2959427T3 (enExample)
MX (2) MX2015003564A (enExample)
NZ (2) NZ707174A (enExample)
PL (1) PL3524260T3 (enExample)
PT (1) PT3524260T (enExample)
RU (1) RU2648958C2 (enExample)
TW (3) TW202106298A (enExample)
WO (1) WO2014052780A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012141061A (ru) 2010-02-26 2014-04-10 Раквалиа Фарма Инк. Агонист рецептора грелина для лечения кахексии
US10039813B2 (en) 2012-02-07 2018-08-07 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
KR20230097201A (ko) 2012-09-27 2023-06-30 아라타나 세라퓨틱스, 인크. 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
WO2014144231A1 (en) 2013-03-15 2014-09-18 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
MX383741B (es) * 2015-01-28 2025-03-04 Aratana Therapeutics Inc Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso.
WO2016138099A1 (en) 2015-02-24 2016-09-01 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
EP3525597A1 (en) * 2016-11-11 2019-08-21 Hill's Pet Nutrition, Inc. Compositions and methods of pet food

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US193273A (en) * 1877-07-17 Improvement in material for pulley-covers
JP2893901B2 (ja) * 1990-09-07 1999-05-24 株式会社岐阜免疫研究所 動物用抗体含有油性ペースト製剤
CA2095786A1 (en) 1992-05-08 1993-11-09 Franco J. Vaccarino Method of stimulating appetite
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
DE60140285D1 (de) 2000-05-31 2009-12-10 Pfizer Prod Inc Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts
EP1181933A3 (en) 2000-06-29 2002-04-10 Pfizer Products Inc. Use of growth hormone secretagogues for stimulating or increasing appetite
US8309603B2 (en) * 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US7491695B2 (en) * 2003-06-18 2009-02-17 Tranzyme Pharma Inc. Methods of using macrocyclic modulators of the ghrelin receptor
US7476653B2 (en) * 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CA2603295A1 (en) * 2004-04-07 2006-10-20 Gastrotech Pharma A/S Use of ghrelin for the treatment of hyperthyroidism
WO2006045313A2 (en) * 2004-10-27 2006-05-04 Gastrotech Pharma A/S Uses of secretagogues for treatment of organ transplant patients
WO2007051629A1 (en) 2005-11-02 2007-05-10 Nestec S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
US7981860B2 (en) * 2006-03-13 2011-07-19 Liat Mintz Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation
NZ576470A (en) 2006-09-27 2012-09-28 Ipsen Pharma Sas Analogs of ghrelin substituted at the n-terminal
JP2008127377A (ja) * 2006-11-24 2008-06-05 Jichi Medical Univ Ｇｈｓ−ｒ作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。
US20080226802A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Beverage having natural sweeteners with one or more stevia components and source of berry
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
RU2007129408A (ru) * 2007-07-31 2009-02-10 Игорь Николаевич Жирков (RU) Способ выращивания поросят в период откорма
FR2920295B1 (fr) * 2007-09-05 2009-12-11 Desvac Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable
WO2009063921A1 (ja) * 2007-11-12 2009-05-22 San-Ei Gen F.F.I., Inc. ステビア抽出物の甘味質改善
AU2010228220B2 (en) 2009-03-26 2015-05-21 Takeda Pharmaceutical Company Limited Pyrazole compound
RU2012141061A (ru) * 2010-02-26 2014-04-10 Раквалиа Фарма Инк. Агонист рецептора грелина для лечения кахексии
KR20230097201A (ko) 2012-09-27 2023-06-30 아라타나 세라퓨틱스, 인크. 식욕부진을 조절 화합물 조성물 및 이의 이용 방법

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Carpino PA, et al."Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin", Bioorg Med Chem. 2003 Feb 20;11(4):581-90.
Carpino PA, et al."Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin", Bioorg Med Chem. 2003 Feb 20;11(4):581-90. P C Bates,et al."Interactions between growth hormone and nutrition in hypophysectomized rats: body composition and production of insulin-like growth factor-I ",J Endocrinol, 1993 Oct;139(1):117-26. *
P C Bates,et al."Interactions between growth hormone and nutrition in hypophysectomized rats: body composition and production of insulin-like growth factor-I ",J Endocrinol, 1993 Oct;139(1):117-26.

Also Published As

Publication number Publication date
PT3524260T (pt) 2023-10-13
JP6796097B2 (ja) 2020-12-02
TW202106298A (zh) 2021-02-16
AR092713A1 (es) 2015-04-29
US11090292B2 (en) 2021-08-17
CN105072909A (zh) 2015-11-18
MX2015003564A (es) 2015-11-16
KR20150058345A (ko) 2015-05-28
EP2906041A2 (en) 2015-08-19
WO2014052780A3 (en) 2014-06-26
TW201924680A (zh) 2019-07-01
JP2016500660A (ja) 2016-01-14
WO2014052780A2 (en) 2014-04-03
CA2886091C (en) 2021-11-30
NZ707174A (en) 2018-10-26
KR20210009438A (ko) 2021-01-26
KR20190143484A (ko) 2019-12-30
KR20220003640A (ko) 2022-01-10
BR112015006282A2 (pt) 2017-07-04
AU2013323349A1 (en) 2015-05-07
EP4302825A2 (en) 2024-01-10
KR20230097201A (ko) 2023-06-30
EP4302825A3 (en) 2024-07-03
RU2015114996A (ru) 2016-11-20
EP3524260B1 (en) 2023-09-13
RU2648958C2 (ru) 2018-03-28
TWI667024B (zh) 2019-08-01
ES2959427T3 (es) 2024-02-26
CA2886091A1 (en) 2014-04-03
TW201417812A (zh) 2014-05-16
AU2013323349B2 (en) 2016-09-15
AU2016216741B2 (en) 2018-02-15
KR20250048114A (ko) 2025-04-07
BR112015006282B1 (pt) 2021-11-23
EP2906041A4 (en) 2016-10-26
JP6779618B2 (ja) 2020-11-04
PL3524260T3 (pl) 2023-11-27
AU2016216741A1 (en) 2016-09-15
DK3524260T3 (da) 2023-10-09
NZ746394A (en) 2019-01-25
MX2022015141A (es) 2023-02-01
EP3524260A1 (en) 2019-08-14
US20140088139A1 (en) 2014-03-27
AR123902A2 (es) 2023-01-25
CN111419845A (zh) 2020-07-17
JP2018117625A (ja) 2018-08-02

Similar Documents

Publication Publication Date Title
JP6796097B2 (ja) 食欲不振制御化合物の組成物および使用方法
JP7120718B2 (ja) 体重増加用化合物の長期使用のための組成物と方法
HK40104431A (en) Pharmaceutical compositions for treatment of inappetence